World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
122
Citations
53777
World Ranking
3482
National Ranking
145

Overview

C. Blake Gilks is affiliated with the University of British Columbia in Canada. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Within these broad disciplines, their work focuses on several subfields including Reproductive Medicine, Obstetrics and Gynecology, Molecular Biology, Epidemiology, and Pathology and Forensic Medicine.

The main topics of Gilks' research address various aspects of cancer diagnosis and treatment with a significant focus on ovarian, endometrial, and cervical cancers. Specific research topics include:

  • Ovarian cancer diagnosis and treatment
  • Endometrial and Cervical Cancer Treatments
  • Cervical Cancer and HPV Research
  • Sarcoma Diagnosis and Treatment
  • Cancer Mechanisms and Therapy
  • Genetic factors in colorectal cancer
  • Cancer-related Molecular Pathways

Gilks has contributed to several recent papers, some of which are:

  • Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis, 2021, published in Cancer
  • p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification, 2021, published in International Journal of Gynecological Cancer
  • Therapeutic options for mucinous ovarian carcinoma, 2020, published in Gynecologic Oncology
  • Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome, 2020, published in Modern Pathology
  • Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines, 2020, published in Gynecologic Oncology

Frequent publication venues for Gilks include:

  • Gynecologic Oncology
  • Modern Pathology
  • International Journal of Gynecological Pathology
  • Clinical Cancer Research
  • Cancer

The scientist has collaborated frequently with a number of coauthors, notably:

  • Jessica N. McAlpine
  • David G. Huntsman
  • Martin Köbel
  • Samuel Leung
  • Aline Talhouk

In addition to journal publications, Gilks has also contributed to academic books. One of their book publications is:

  • Tumors of the Ovary and Fallopian Tube, published in 2023 by American Registry of PathologyArlington, Virginia eBooks

Best Publications

  • Integrated genomic characterization of endometrial carcinoma

    Gad Getz;Stacey B. Gabriel;Kristian Cibulskis;Eric Lander

  • Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

    Torsten O. Nielsen;Forrest D. Hsu;Kristin Jensen;Maggie Cheang

  • Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T reg cells

    Andrea Facciabene;Xiaohui Peng;Ian S. Hagemann;Klara Balint

  • Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies

    Martin Köbel;Martin Köbel;Steve E Kalloger;Niki Boyd;Steven McKinney

  • Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary

    Sohrab P Shah;Martin Köbel;Janine Senz;Ryan D Morin

  • A clinically applicable molecular-based classification for endometrial cancers

    A. Talhouk;M. K. McConechy;S. Leung;H. H. Li-Chang

  • Confirmation of ProMisE: A simple, genomics‐based clinical classifier for endometrial cancer

    Aline Talhouk;Melissa K. McConechy;Samuel Leung;Winnie Yang

  • A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.

    Robert B. West;Brian P. Rubin;Melinda A. Miller;Subbaya Subramanian

  • Cancer-Associated Mutations in Endometriosis without Cancer

    Michael S. Anglesio;Nickolas Papadopoulos;Ayse Ayhan;Tayyebeh M. Nazeran

  • Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

    S. Kommoss;M. K. McConechy;F. Kommoss;S. Leung

  • Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors

    Katy Milne;Martin Köbel;Steven E. Kalloger;Rebecca O. Barnes

  • Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

    Weiva Sieh;Martin Köbel;Teri A Longacre;David D Bowtell;David D Bowtell

  • Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma.

    C. Blake Gilks;Esther Oliva;Robert A. Soslow

  • Differences in tumor type in low-stage versus high-stage ovarian carcinomas.

    Martin Köbel;Steve E. Kalloger;David G. Huntsman;Jennifer L. Santos

  • TITAN: inference of copy number architectures in clonal cell populations from tumor whole-genome sequence data

    Gavin Ha;Gavin Ha;Andrew Roth;Andrew Roth;Jaswinder Khattra;Julie Ho

  • Gene Expression Profiling Reveals Reproducible Human Lung Adenocarcinoma Subtypes in Multiple Independent Patient Cohorts

    D. Neil Hayes;Stefano Monti;Giovanni Parmigiani;C. Blake Gilks

  • Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities.

    Joshua Z Press;Alessandro De Luca;Niki Boyd;Sean Young;Sean Young

  • Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer

    Andrew McPherson;Andrew Roth;Andrew Roth;Emma Laks;Tehmina Masud;Tehmina Masud

  • Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss

    Blaise Clarke;Anna V. Tinker;Cheng Han Lee;Subbaya Subramanian

  • Use of mutation profiles to refine the classification of endometrial carcinomas.

    Melissa K McConechy;Jiarui Ding;Jiarui Ding;Maggie Cu Cheang;Kimberly C Wiegand

Frequent Co-Authors

David G. Huntsman
David G. Huntsman University of British Columbia
Martin Köbel
Martin Köbel University of Calgary
Torsten O. Nielsen
Torsten O. Nielsen University of British Columbia
Robert A. Soslow
Robert A. Soslow Memorial Sloan Kettering Cancer Center
Sohrab P. Shah
Sohrab P. Shah Memorial Sloan Kettering Cancer Center
Matt van de Rijn
Matt van de Rijn Stanford University
Esther Oliva
Esther Oliva Harvard University
Maggie C.U. Cheang
Maggie C.U. Cheang Institute of Cancer Research
Brad H. Nelson
Brad H. Nelson University of British Columbia
David D.L. Bowtell
David D.L. Bowtell Peter MacCallum Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine or expanding their healthcare careers, there are several flexible online degree options worth considering. For those drawn to nutrition and wellness, online nutrition degrees offer comprehensive study into diet, health, and disease prevention—all accessible remotely.

Many aspiring healthcare administrators seek programs that are not only convenient but also well respected. Prospective leaders should explore which online healthcare degree programs are recognized for their accreditation by cahme? to ensure their qualifications are valued by employers nationwide.

Registered nurses looking to advance can benefit from best online rn to bsn programs without clinical requirements, making it possible to obtain a bachelor’s degree while balancing work and personal obligations.

For nurses seeking a terminal degree, numerous online dnp programs provide the chance to move into leadership, education, or advanced practice roles in a flexible format. Exploring these pathways can open up rewarding career trajectories within the diverse healthcare landscape.

Best Scientists Citing C. Blake Gilks

Trending Scientists

Recently Published Articles